BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 24738483)

  • 1. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent therapeutic advances in juvenile idiopathic arthritis.
    Giancane G; Alongi A; Rosina S; Tibaldi J; Consolaro A; Ravelli A
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):476-487. PubMed ID: 29773268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids in juvenile idiopathic arthritis.
    Schiappapietra B; Varnier G; Rosina S; Consolaro A; Martini A; Ravelli A
    Neuroimmunomodulation; 2015; 22(1-2):112-8. PubMed ID: 25227183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid treatment in juvenile idiopathic arthritis.
    Batu ED
    Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile idiopathic arthritis (JIA): a screening study to measure class II skeletal pattern, TMJ PDS and use of systemic corticosteroids.
    Mandall NA; Gray R; O'Brien KD; Baildam E; Macfarlane TV; Davidson J; Sills J; Foster H; Gardner-Medwin J; Garrahy A; Millett D; Mattick R; Walsh T; Ward S
    J Orthod; 2010 Mar; 37(1):6-15. PubMed ID: 20439922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate: new uses for an old drug.
    Hashkes PJ; Becker ML; Cabral DA; Laxer RM; Paller AS; Rabinovich CE; Turner D; Zulian F
    J Pediatr; 2014 Feb; 164(2):231-6. PubMed ID: 24286573
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
    Cuende E; Vesga JC; Pérez LB; Ardanaz MT; Guinea J
    Clin Exp Rheumatol; 2001; 19(6):764-5. PubMed ID: 11791663
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis.
    Afonso Pérez E; Garcia Porrua C; Castiñeiras Mato IM; Bal Nieves F
    Reumatol Clin; 2012; 8(6):380-1. PubMed ID: 22858519
    [No Abstract]   [Full Text] [Related]  

  • 12. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the treatment of juvenile idiopathic arthritis.
    Harris JG; Kessler EA; Verbsky JW
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):337-46. PubMed ID: 23605168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
    Livermore P
    Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for juvenile idiopathic arthritis.
    Klein A; Horneff G
    Expert Opin Pharmacother; 2009 Dec; 10(18):3049-60. PubMed ID: 19954274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis.
    Yu EN; Meniconi ME; Tufail F; Baltatzis S; Foster CS
    Ocul Immunol Inflamm; 2005; 13(5):353-60. PubMed ID: 16419420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of juvenile idiopathic arthritis.
    Hashkes PJ; Laxer RM
    JAMA; 2005 Oct; 294(13):1671-84. PubMed ID: 16204667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Judicious use of biologicals in juvenile idiopathic arthritis.
    Zhao Y; Wallace C
    Curr Rheumatol Rep; 2014 Nov; 16(11):454. PubMed ID: 25218736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication.
    Heiligenhaus A; Mingels A; Heinz C; Ganser G
    Eur J Ophthalmol; 2007; 17(5):743-8. PubMed ID: 17932849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.